Alliqua BioMedical Forecast and Stock Analysis
Technical ALQA stock analysis for April 24, 2019.
Alliqua BioMedical fell by -10.22% in the last day from $2.74 to $2.46 and has now fallen 3 days in a row. The price has fallen in 7 of the last 10 days and is down by -10.87% for this period. Volume has increased in the last day by 66 602 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 129 284 shares bought and sold for approximately $318 039.00.
Close price at the end of the last trading day (Wednesday, 24th Apr 2019) of the ALQA stock was $2.46. This is 10.22% less than the trading day before Tuesday, 23rd Apr 2019.
During day the stock fluctuated 12.81% from a day low at $2.42 to a day high of $2.73.
30 day high of the ALQA stock price was $3.24 and low was $2.42.
90 day high was $3.65 and low was $2.16.
52 week high for the Alliqua BioMedical - $5.24 and low - $1.55.
Alliqua BioMedical has broken the very wide and strong rising short-term trend down. This signalize a slower rising rate, but may also be an early warning about a possible trend shift. Due to trend being broken there will now be resistance at the bottom line of the trend at $2.62. A reaction back to this level may hold a second chance to get out before further falls.
There are few to none technical positive signals at the moment. Alliqua BioMedical holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.76 and $2.82. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Monday April 22, 2019, which indicates further falls until a new bottom pivot has been found. Alliqua BioMedical gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".
* Golden Star Signal* is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Relative Strength Index (RSI)
RSI14 is 41 and the stock is currently not being overbought or oversold
Support & Resistance
Alliqua BioMedical finds support from accumulated volume at $2.44.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.31 (12.81%) between high and low. For the last week, the stock has had a daily average volatility of 8.70%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
The Alliqua BioMedical stock holds several negative signals and despite the positive trend we believe Alliqua BioMedical will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|ALQA $2.46 ($-0.28 -10.22%)|
ALQA is down $0.28 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ALQA based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ALQA analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us